Drug recall · July 18, 2018
Nitrofurantoin Oral Suspension USP recall
Why: Subpotent Drug and Failed Content Uniformity.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Nitrofurantoin Oral Suspension USP, 25mg/5mL, 230 mL Bottle, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, UPC 343386-450-114, NDC 43386-450-11
- Lots / codes
Lot#: S700065, Exp. 02/2019; 700619, Exp. 08/2019
- Quantity
- 3456 cartons
- Company
- Lupin Somerset, Somerset, NJ
- Distribution
- Nationwide within the US
- Initiated
- June 28, 2018 · Voluntary: Firm initiated
- Classified
- July 18, 2018
- Reported
- July 18, 2018
- Ended
- March 6, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nitrofurantoin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.